Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 252 results found since Jan 2013.
A Case Report of Varicella Zoster Meningitis as Co-Infection With Breakthrough COVID-19 in an Immunocompetent Patient
J Korean Med Sci. 2022 Feb 28;37(8):e61. doi: 10.3346/jkms.2022.37.e61.ABSTRACTThere are several previous reports that infection or reactivation of varicella zoster virus (VZV) can occur after coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Herein, we report a rare case of VZV meningitis in breakthrough COVID-19. An 18-years-old male visited the emergency room, presenting with a headache and fever of up to 38.4°C for 5 days. He received the second dose of BNT162b2 mRNA SARS-CoV-2 vaccine 7 weeks prior to symptom onset. The symptoms persisted with headac...
Source: J Korean Med Sci - February 28, 2022 Category: General Medicine Authors: SeungHoon Yun Jinyong Kim Hye-Rim Shin Source Type: research
Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
J Ophthalmic Vis Res. 2022 Jan 21;17(1):123-129. doi: 10.18502/jovr.v17i1.10177. eCollection 2022 Jan-Mar.ABSTRACTHerpes zoster ophthalmicus is a frequent, painful, and debilitating condition caused by the reactivation of the varicella-zoster virus alongside the ophthalmic branch of the trigeminal nerve. Twenty-five percent of adults will develop the disease during their lifetime with the risk increasing to one in two over the age of 50. Herpes zoster ophthalmicus presents with a plethora of ocular manifestations ranging from the characteristic rash in the distribution of the ophthalmic branch of the fifth cranial nerve to...
Source: Journal of Ophthalmic and Vision Research - February 23, 2022 Category: Opthalmology Authors: Michael Tsatsos Ioannis Athanasiadis Athina Myrou George M Saleh Nikolaos Ziakas Source Type: research
